Endocrine Aspects of Prostate Cancer
Prostatic cancer in the year 2000 will be at the forefront of medical problems affecting the male population of the world. There is now a considerable amount of evidence to indicate that cancer of the prostate gland is, or is quickly becoming, the most commonly diagnosed cancer in men in the western world. The incidence rate appears to be consistently rising and, interestingly, the mortality rate for the black population of the United States of America is double that of the white people. It is becoming very evident that prostatic disease, both benign prostatic hyperplasia (BPH) as well as cancer, has become a serious health-care problem, particularly when considered in relation to the ever increasing proportion of the population in the more developed countries that is over the age of 65 years.
KeywordsProstatic Cancer Androgen Receptor Proliferate Cell Nuclear Antigen Estramustine Phosphate Atypical Adenomatous Hyperplasia
Unable to display preview. Download preview PDF.
- 5.Griffiths K, Davies P, Eaton CL, Harper ME, Turkes A and Peeling WB: Endocrine factors in the initiation, diagnosis and treatment of prostatic cancer. In: Voigt KD and Knabbe C (eds) Endocrine Dependent Tumors. Raven Press Ltd, New York 1991 pp 83–130Google Scholar
- 8.Folkman, J: Toward an understanding of angio-genesis: search and discovery. Perspect in Biol and Med 1985 (29):10–36Google Scholar